Ebba Sjögren
Biographic Data
| ID | 1140306 |
|---|---|
| NAME | Ebba Sjögren |
| GIVEN NAMES | Ebba |
| FAMILY NAME | Sjögren |
| SIGNATURE | SJÖGREN E |
| AFFILIATIONS | Stockholm School of Economics |
| ORCID | 0000-0001-6588-9865 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 29 |
| WORKS AS AUTHOR | 10 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 4 |
No finish line
This article analyses how formalization of promotion criteria and procedures influences clarity and transparency of academic assessment. Based on a longitudinal, structural micro‐study of a new tenure track system in a Swedish higher education institution, we find that inequality was reproduced through the choice of explicitly gendered metrics across all areas of assessment (research, teaching and service). We further demonstrate how the formaliz…
Five years! Have we not had enough of valuation studies by now
Not Available
Glocal Pharma
An exploration of how global pharmaceutical products are localized - of what happens when they become ’glocal’ - this book examines the tensions that exist between a global pharmaceutical market and the locally bounded discourses and regulations encountered as markets are created for new drugs in particular contexts. Employing the case study of the emergence, representation and regulation of Viagra in the Swedish market, Glocal Pharma offers anal…
Valuation and Calculation at the Margins
Not Available
Valuation Studies and the Critique of Valuation
The Legal Mind of the Internal Market
The purpose of this article is to contribute to the understanding of the broader effects of monitoring practices in the European Union. The empirical setting is Solvit, a Commission‐initiated network tasked with informal resolution of misapplications of internal market directives by national authorities. All Member States must operate a Solvit centre within their administrations. Using a governmentality approach, the article investigates the norm…
More Knowledge, Better Government? Consequences of Knowledge-Based Decision Making in Swedish Pharmaceutical Benefits
Using an example from the health-care sector, we illustrate consequences of implementing knowledge-based decision making relating to the exercise of political control. The Swedish Pharmaceutical Benefits Board decides the subsidization status of prescription pharmaceuticals. Building on a study of the agency's work, we explore the effects of institutional arrangements stemming from rationalistic demands for knowledgeable and justifiable outcomes …
Upsetting categories? The consequences of pharmacogenomics for making knowledge-based reimbursement decisions in Sweden
This paper contributes to an understanding of pharmacogenomics-in-the-making by foregrounding a regulatory setting in which these technologies must be situated: decision-making about pharmaceutical reimbursement. Health care assessment organizations have been introduced in many countries to systematically address the issue of health care coverage. Using the example of Sweden, the process of deciding reimbursement status is shown to hinge on the c…
Defining ‘Markets’ for Pharmaceuticals in Sweden
The Q(u)ALYfying Hand
The Q(u)ALYfying hand: health economies and medicine in the shaping of Swedish markets for subsidized pharmaceuticals
The Q(u)ALYfying Hand
The Q(u)ALYfying hand: health economies and medicine in the shaping of Swedish markets for subsidized pharmaceuticals
More Knowledge, Better Government? Consequences of Knowledge-Based Decision Making in Swedish Pharmaceutical Benefits
Using an example from the health-care sector, we illustrate consequences of implementing knowledge-based decision making relating to the exercise of political control. The Swedish Pharmaceutical Benefits Board decides the subsidization status of prescription pharmaceuticals. Building on a study of the agency's work, we explore the effects of institutional arrangements stemming from rationalistic demands for knowledgeable and justifiable outcomes …
The Legal Mind of the Internal Market
The purpose of this article is to contribute to the understanding of the broader effects of monitoring practices in the European Union. The empirical setting is Solvit, a Commission‐initiated network tasked with informal resolution of misapplications of internal market directives by national authorities. All Member States must operate a Solvit centre within their administrations. Using a governmentality approach, the article investigates the norm…
No finish line
This article analyses how formalization of promotion criteria and procedures influences clarity and transparency of academic assessment. Based on a longitudinal, structural micro‐study of a new tenure track system in a Swedish higher education institution, we find that inequality was reproduced through the choice of explicitly gendered metrics across all areas of assessment (research, teaching and service). We further demonstrate how the formaliz…
Defining ‘Markets’ for Pharmaceuticals in Sweden
The Q(u)ALYfying Hand
The Q(u)ALYfying hand: health economies and medicine in the shaping of Swedish markets for subsidized pharmaceuticals
Upsetting categories? The consequences of pharmacogenomics for making knowledge-based reimbursement decisions in Sweden
This paper contributes to an understanding of pharmacogenomics-in-the-making by foregrounding a regulatory setting in which these technologies must be situated: decision-making about pharmaceutical reimbursement. Health care assessment organizations have been introduced in many countries to systematically address the issue of health care coverage. Using the example of Sweden, the process of deciding reimbursement status is shown to hinge on the c…
More Knowledge, Better Government? Consequences of Knowledge-Based Decision Making in Swedish Pharmaceutical Benefits
Using an example from the health-care sector, we illustrate consequences of implementing knowledge-based decision making relating to the exercise of political control. The Swedish Pharmaceutical Benefits Board decides the subsidization status of prescription pharmaceuticals. Building on a study of the agency's work, we explore the effects of institutional arrangements stemming from rationalistic demands for knowledgeable and justifiable outcomes …
Valuation Studies and the Critique of Valuation
The Legal Mind of the Internal Market
The purpose of this article is to contribute to the understanding of the broader effects of monitoring practices in the European Union. The empirical setting is Solvit, a Commission‐initiated network tasked with informal resolution of misapplications of internal market directives by national authorities. All Member States must operate a Solvit centre within their administrations. Using a governmentality approach, the article investigates the norm…
Valuation and Calculation at the Margins
Not Available
Glocal Pharma
An exploration of how global pharmaceutical products are localized - of what happens when they become ’glocal’ - this book examines the tensions that exist between a global pharmaceutical market and the locally bounded discourses and regulations encountered as markets are created for new drugs in particular contexts. Employing the case study of the emergence, representation and regulation of Viagra in the Swedish market, Glocal Pharma offers anal…
Five years! Have we not had enough of valuation studies by now
Not Available
No finish line
This article analyses how formalization of promotion criteria and procedures influences clarity and transparency of academic assessment. Based on a longitudinal, structural micro‐study of a new tenure track system in a Swedish higher education institution, we find that inequality was reproduced through the choice of explicitly gendered metrics across all areas of assessment (research, teaching and service). We further demonstrate how the formaliz…
Economics (6 works) · Business (5 works) · Computer Science (4 works) · Law (4 works) · Political science (4 works) · Public relations (4 works) · Sociology (4 works) · Accounting (3 works) · Law (3 works) · Pharmaceutical Economics and Policy (3 works)